LCTX · TickerCove

LCTXLineage Cell Therapeutics, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $1.07 · now $1.07 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, LCTX has typically landed between $0.85 and $1.34 — a range of −20.4% to +25.5% from the issuance price $1.07.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

5,002 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.07) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$1.07 · 6% of range

$1.01 low$1.96 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−2.3%

typical move · IQR 16.5%

−20.4%worst (p90)+25.5%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where LCTX has typically landed a month from the 2026-09-16 close of $1.07 — the range is history, not a prediction.

now $1.07 (+0.0%)
typical $1.05 (-2.3%)
middle 50% $0.9572–$1.13
90% range $0.8517–$1.34

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,002 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2020-02-18	−60.5%	−60.5%	+0.0%
2020-02-13	−58.6%	−58.6%	+0.0%
2020-02-11	−57.0%	−57.0%	+0.0%
3 best
2007-01-05	+177.8%	+0.0%	+177.8%
2008-08-01	+171.2%	+0.0%	+171.2%
2007-01-03	+161.5%	+0.0%	+161.5%

5,002 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

60%

+11.0%

n=20

Feb

35%

−2.4%

n=20

Mar

65%

+5.9%

n=20

Apr

40%

−0.8%

n=20

May

45%

+0.3%

n=20

Jun

40%

+2.1%

n=20

Jul

45%

+1.6%

n=20

Aug

40%

+3.6%

n=20

Sep

50%

+4.9%

n=20

Oct

50%

+6.2%

n=20

Nov

40%

+3.7%

n=20

Dec

45%

−2.2%

n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-03-12	Culley Brian M	director	Purchase	15,000 @ $1.63	$24K	+6.2% of holding	−7.7%	−51.4%	255,516	Form 4 · filed same day
2025-01-27	BROADWOOD PARTNERS, L.P.	director	Purchase	7,894,737 @ $0.76	$6.0M	+18.9% of holding	+2.7%	+67.4%	49,560,992	Form 4 · filed 1 day after the trade
2025-01-27	BROADWOOD PARTNERS, L.P.	director	Purchase	0 @ $0.00	$0	+0.0% of holding	+2.7%	+67.4%	49,560,992	Form 4 · filed 1 day after the trade
2025-01-27	BROADWOOD PARTNERS, L.P.	director	Purchase	0 @ $0.00	$0	+0.0% of holding	+2.7%	+67.4%	7,894,737	Form 4 · filed 1 day after the trade
2025-01-27	BROADWOOD PARTNERS, L.P.	director	Purchase	7,894,737 @ $0.00	$0	ownership Δ n/a	+2.7%	+67.4%	7,894,737	Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

40 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-01	ANDREWS DEBORAH J	director	Award / grant	125,000	125,000	Form 4
2026-07-01	Jayasuriya Anula	director	Award / grant	125,000	125,000	Form 4
2026-07-01	Russell Angus C.	director	Award / grant	125,000	125,000	Form 4
2026-07-01	Mulroy Michael H.	director	Award / grant	125,000	125,000	Form 4
2026-07-01	Bradsher Neal C	director	Award / grant	125,000	125,000	Form 4
2026-07-01	Amin Dipti	director	Award / grant	125,000	125,000	Form 4
2026-03-05	Howe Jill Ann	officer	Award / grant	1,050,000	1,050,000	Form 4
2026-03-05	Culley Brian M	director	Award / grant	3,250,000	3,250,000	Form 4
2026-03-05	Samuel George A. III	officer	Award / grant	900,000	900,000	Form 4
2026-02-11	Culley Brian M	director	Withheld for tax	12,869	240,516	Form 4
2026-02-11	Samuel George A. III	officer	Withheld for tax	2,502	31,063	Form 4
2026-02-11	Samuel George A. III	officer	Option exercise	6,075	0	Form 4
2026-02-11	Culley Brian M	director	Option exercise	31,250	0	Form 4
2026-02-11	Culley Brian M	director	Option exercise	31,250	253,385	Form 4
2026-02-11	Samuel George A. III	officer	Option exercise	6,075	33,565	Form 4
2026-02-11	Culley Brian M	director	Option exercise	31,250	253,385	Form 4
2026-02-11	Samuel George A. III	officer	Option exercise	6,075	33,565	Form 4
2025-12-19	Culley Brian M	director	Withheld for tax	334	222,135	Form 4
2025-12-19	Samuel George A. III	officer	Withheld for tax	65	27,490	Form 4
2025-12-19	Samuel George A. III	officer	Award / grant	1,735	27,555	Form 4
2025-12-19	Culley Brian M	director	Award / grant	8,925	222,469	Form 4
2025-12-19	Samuel George A. III	officer	Award / grant	1,735	27,555	Form 4
2025-12-19	Culley Brian M	director	Award / grant	8,925	222,469	Form 4
2025-07-01	Jayasuriya Anula	director	Award / grant	75,000	75,000	Form 4
2025-07-01	Amin Dipti	director	Award / grant	75,000	75,000	Form 4
2025-07-01	ANDREWS DEBORAH J	director	Award / grant	75,000	75,000	Form 4
2025-07-01	Mulroy Michael H.	director	Award / grant	75,000	75,000	Form 4
2025-07-01	Russell Angus C.	director	Award / grant	75,000	75,000	Form 4
2025-07-01	Bradsher Neal C	director	Award / grant	75,000	75,000	Form 4
2025-03-10	Culley Brian M	director	Award / grant	2,300,000	2,300,000	Form 4
2025-03-10	Howe Jill Ann	officer	Award / grant	750,000	750,000	Form 4
2025-03-10	Samuel George A. III	officer	Award / grant	750,000	750,000	Form 4
2025-02-11	Culley Brian M	director	Withheld for tax	12,547	213,544	Form 4
2025-02-11	Samuel George A. III	officer	Withheld for tax	2,440	25,820	Form 4
2025-02-11	Culley Brian M	director	Option exercise	31,249	31,250	Form 4
2025-02-11	Samuel George A. III	officer	Option exercise	6,076	6,075	Form 4
2025-02-11	Culley Brian M	director	Option exercise	31,249	226,091	Form 4
2025-02-11	Culley Brian M	director	Option exercise	31,249	226,091	Form 4
2025-02-11	Samuel George A. III	officer	Option exercise	6,076	28,260	Form 4
2025-02-11	Samuel George A. III	officer	Option exercise	6,076	28,260	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i